News | January 03, 2011

Digital Pathology Image Analysis for Breast Cancer Diagnosis

January 3, 2011 — Royal Philips Electronics and Definiens, a health image intelligence company, have signed a cooperation agreement to jointly develop a digital pathology system to support clinical diagnosis of several types of cancer, beginning with breast cancer. The companies will integrate Definiens’ image analysis solutions into Philips’ imaging systems, providing pathologists with tools for assessment of immunohistochemically stained cancer tissue.

Pathologists examine tissue slices treated with appropriate stains to reveal specific biomarkers of disease (such as cancer-related proteins) or the structure of tissues, which can indicate disease state. By automating biomarker expression analysis and characterization of tissue morphology, Philips and Definiens aim to help pathologists generate more consistent and standardized data from tissue samples. The automated process will provide oncologists and physicians with comprehensive data designed to enhance treatment decisions and patient care.

In the initial project, the companies will focus on immunohistology-based breast cancer diagnostics, including biomarkers such as HER2/neu, estrogen receptor (ER), progesterone receptor (PR), Ki-67 and p53. Subsequently, Definiens plans to develop software to support analysis of hematoxylin and eosin (H&E) stained tissue. The companies also plan to develop similar approaches for other cancers, such as prostate and colon cancer.

For more information: www.philips.com, www.definiens.com

Related Content

VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
News | Artificial Intelligence | May 08, 2019
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to...
Georgia Becomes 38th State With Breast Density Inform Law
News | Breast Density | May 06, 2019
Georgia Gov. Brian Kemp signed breast density inform bill HB62 into law May 3, 2019. The law, which becomes effective...
American Society of Breast Surgeons Issues Risk-based Screening Mammography Guidelines
News | Mammography | May 03, 2019
The American Society of Breast Surgeons (ASBrS) has released the first screening mammography guidelines based on a...
Hologic Launches Trident HD Specimen Radiography System
Technology | Breast Biopsy Systems | April 26, 2019
Hologic Inc. announced global commercial availability of the Trident HD specimen radiography system. The next-...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Women With Coronary Artery Wall Thickness at Risk for Heart Disease
News | Cardiac Imaging | April 25, 2019
The thickness of the coronary artery wall as measured by magnetic resonance imaging (MRI) is an independent marker for...